We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+4.67%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.05B
AUM Growth
+$276M
(+4.1%)
Cap. Flow
+$73M
Cap. Flow
% of AUM
1.04%
Top 10 Holdings %
Top 10 Hldgs %
27.96%
Holding
1,430
New
433
Increased
334
Reduced
305
Closed
319
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$182M |
| 2 |
ENDP
Endo International plc
ENDP
|
+$170M |
| 3 |
AET
Aetna Inc
AET
|
+$131M |
| 4 |
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
|
+$108M |
| 5 |
Brookdale Senior Living
BKD
|
+$91.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$435M |
| 2 |
Elevance Health
ELV
|
+$121M |
| 3 |
Cigna
CI
|
+$119M |
| 4 |
WMGI
Wright Medical Group Inc
WMGI
|
+$82.7M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$72.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 49.34% |
| 2 | Financials | 7.86% |
| 3 | Consumer Discretionary | 7.17% |
| 4 | Technology | 6.32% |
| 5 | Industrials | 4.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BNY
226
Bank of New York Mellon
BNY
$106B
| $6.87M | 0.1% |
163,629
+135,479
| +481% | +$5.77M |
|
|
ALTR
227
DELISTED
Altera Corp
ALTR
| $6.82M | 0.1% |
133,249
+82,775
| +164% | +$3.86M |
|
|
WWAV
228
DELISTED
The WhiteWave Foods Company
WWAV
| $6.77M | 0.1% |
138,525
+34,194
| +33% | +$1.6M |
|
229
Marvell Technology
MRVL
$168B
| $6.71M | 0.1% |
509,020
+188,811
| +59% | +$2.71M |
|
|
NATL
230
DELISTED
National Interstate Corporation
NATL
| $6.69M | 0.09% |
244,726
+63,909
| +35% | +$1.76M |
|
231
Applied Materials
AMAT
$403B
| $6.67M | 0.09% |
347,142
-497,547
| -59% | -$10.2M |
|
|
SPN
232
DELISTED
Superior Energy Services, Inc.
SPN
| $6.65M | 0.09% |
+31,595
| New | +$7.39M |
|
233
ManpowerGroup
MAN
$2.44B
| $6.58M | 0.09% |
73,633
+70,784
| +2,485% | +$6.1M |
|
234
FirstEnergy
FE
$28B
| $6.53M | 0.09% |
200,510
+189,397
| +1,704% | +$6.62M |
|
235
Norwegian Cruise Line
NCLH
$8.51B
| $6.5M | 0.09% |
+115,900
| New | +$6.23M |
|
236
Primerica
PRI
$9.98B
| $6.47M | 0.09% |
+141,651
| New | +$6.62M |
|
237
AMC Global Media
AMCX
$492M
| $6.44M | 0.09% |
78,659
-14,499
| -16% | -$1.13M |
|
|
CXO
238
DELISTED
CONCHO RESOURCES INC.
CXO
| $6.42M | 0.09% |
56,370
-132,611
| -70% | -$16.1M |
|
239
HP
HPQ
$24.9B
| $6.42M | 0.09% |
470,810
+53,767
| +13% | +$798K |
|
|
USG
240
DELISTED
Usg
USG
| $6.39M | 0.09% |
+230,000
| New | +$6.31M |
|
|
VTLE
241
DELISTED
Vital Energy
VTLE
| $6.37M | 0.09% |
25,317
-5,659
| -18% | -$1.62M |
|
|
SNR
242
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
| $6.3M | 0.09% |
471,559
-77,002
| -14% | -$1.22M |
|
|
SEE
243
DELISTED
Sealed Air
SEE
| $6.15M | 0.09% |
119,695
+33,094
| +38% | +$1.59M |
|
|
PGRE
244
DELISTED
Paramount Group
PGRE
| $6.12M | 0.09% |
356,642
+36,328
| +11% | +$669K |
|
|
ETFC
245
DELISTED
E*Trade Financial Corporation
ETFC
| $6.08M | 0.09% |
203,066
-44,207
| -18% | -$1.3M |
|
246
Dycom Industries
DY
$12B
| $5.97M | 0.08% |
+101,400
| New | +$5.37M |
|
247
Gold Fields
GFI
$29B
| $5.96M | 0.08% |
1,843,758
+710,360
| +63% | +$2.66M |
|
248
Sempra
SRE
$57.9B
| $5.94M | 0.08% |
120,062
-96,098
| -44% | -$5.09M |
|
249
Vericel Corp
VCEL
$2.35B
| $5.94M | 0.08% |
1,662,670
+6,824
| +0.4% | +$23.4K |
|
|
FLXN
250
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $5.93M | 0.08% |
271,000
+128
| +0% | +$2.58K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q2 2015 Portfolio in Review
As of Q2 2015, Visium Asset Management held 1,430 positions worth $7.05B, up 4.1% from $6.78B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Visium Asset Management's Q2 2015 filing shows 433 new, 334 increased, 305 reduced and 319 closed positions. Its largest new stake was Sio Gene Therapies Inc. Common Stock: 635,000 shares worth $104M. The largest sale was Allergan plc, an estimated $435M.
By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 49% a quarter earlier, followed by Financials and Consumer Discretionary.
- Visium Asset Management's largest Q2 2015 buy was Sio Gene Therapies Inc. Common Stock: 635,000 shares worth $104M.
- Visium Asset Management added most to Bausch Health in Q2 2015, an estimated $182M increase.
- Visium Asset Management's biggest Q2 2015 reduction was Elevance Health, cutting an estimated $121M.
- Visium Asset Management fully exited Allergan plc in Q2 2015, selling an estimated $435M.
- Visium Asset Management's ten largest holdings make up 28% of its $7.05B portfolio in Q2 2015.
- Visium Asset Management opened 433 new positions and closed 319 in Q2 2015.
- Visium Asset Management's portfolio value rose 4.1% quarter-over-quarter to $7.05B.
Based on Visium Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.